Searchable abstracts of presentations at key conferences in endocrinology

ea0086oc4.1 | Adrenal and Cardiovascular | SFEBES2022

Introducing technology to improve patient safety in adrenal insufficiency: a proof-of-concept delivery of a new smartphone app in steroid-dependent patients

Panagiotou Grigorios , Lewis Janet , Sall Seetal , Lansdown Andrew

Introduction: Although significant developments have been achieved in the management of steroid-dependent patients, little progress has been made in ensuring their safety using smartphone technology. We present the use of a novel app in steroid-dependent patients.Methods: A group of unselected individuals currently on steroid replacement due to adrenal insufficiency (AI) were assessed regarding their access to intramuscular (IM) hydrocortisone. A smartph...

ea0065p336 | Nursing practice | SFEBES2019

Effectiveness of a nurse-led adrenal incidentaloma (AI) clinic at the University Hospital of Wales, Cardiff

Lewis Janet , Hamdan Khaliq , Scholz Anna , Lansdown Andrew

Background: In December 2017, a Nurse-Led AI clinic was introduced at University Hospital of Wales, Cardiff for the evaluation and follow-up of these patients. The clinic pathway was based upon the 2016 European Society for Endocrinology (ESE) guidelines on the management of adrenal incidentalomas.Aim: To evaluate the effectiveness of this new service and the cost-saving benefit.Methods: Electronic and paper-based patient records w...

ea0094p150 | Nursing Practice | SFEBES2023

A service evaluation of the nurse-led adrenal incidentaloma clinic at University Hospital of Wales

Yi Hoong Lee Benjamin , Lewis Janet , Lansdown Andrew

Background: In November 2017, a nurse-led Adrenal Incidentaloma (AI) clinic was launched at the University Hospital of Wales (UHW), Cardiff, based upon the 2016 European Society of Endocrinology AI management guidelines.Objectives: To evaluate the effectiveness of a nurse-led clinic in managing AI patients at UHW.Methods: Retrospective analysis of electronic records of patients see...

ea0046p23 | (1) | UKINETS2016

Evaluation of faecal elastase 1 in symptomatic patients with neuroendocrine tumours

Chaudhry Rayhan , Newbould Rachel , Williams Megan , Reid Kieran , Donnelly Lauren , Lewis Janet , Khan Mohid

Monitoring patients with NETs reveals a significant prevalence of gastrointestinal symptoms, often unrelated directly to the tumour1. Exocrine pancreatic insufficiency exemplifies a common treatable cause of gastrointestinal symptoms in NET patients undergoing therapy with somatostatin analogues. There is a paucity of data regarding this important issue which affects quality of life in NETs. We explored the value of faecal elastase (FE) as a marker of exocrine pancr...

ea0059p017 | Adrenal and steroids | SFEBES2018

Addressing adrenal incidentalomas (AIs): a snapshot of the investigation of AIs in a tertiary endocrine centre and the effect of implementing a local management pathway

Scholz Anna , Rahman Mohammed , Lewis Janet , Gait-Carr Eleanor , Buey Gala Gutierrez , Tang Carolyn , Brooke Jennifer , Ellis-Owen Ruth , Rees Aled , Lansdown Andrew

Introduction: Adrenal incidentalomas (AIs) are found in ~3% abdominal scans, rising to 10% in the elderly. In 2016, the European Society of Endocrinology (ESE) published new guidance on their management.Aims & objectives: To (1) compare how AIs have been managed at the University Hospital of Wales (UHW) against ESE guidelines, and (2) provide an early evaluation of the impact of service changes implemented based on initial findings.<p class="abst...